Skip to main content
. 2011 Oct;30(10):682–689. doi: 10.5732/cjc.011.10188

Figure 1. Progression-free survival (full analysis set) in Chinese patients with metastatic colorectal cancer treated with either bevacizumab plus mIFL or mIFL alone.

Figure 1.

mIFL, modified irinotecan, leucovorin bolus, and 5-fluorouracil intravenous infusion.